Picture of Poxel SA logo

POXEL — Poxel SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Poxel End-March Cash And Cash Equivalents At 10.6 Million Euros

May 17 (Reuters) - Poxel SA  POXEL.PA :
    * POXEL REPORTS CASH AND REVENUE FOR Q1 2023 AND PROVIDES
CORPORATE UPDATE
    * AS OF MARCH 31, 2023, CASH AND CASH EQUIVALENTS WERE EUR
10.6
MILLION
    * TWYMEEG SALES IN JAPAN FOR SUMITOMO PHARMA FISCAL YEAR
20221
EXCEEDED GUIDANCE BY MORE THAN 20%, AND TWYMEEG'S FY 2023
FORECAST FROM SUMITOMO PHARMA WOULD REPRESENT A 90% INCREASE
OVER PRIOR YEAR SALES
    * POXEL REPORTED EUR 449 THOUSAND REVENUE FOR QUARTER ENDED
MARCH
31, 2023

Source text for Eikon:  ID:nBw3JXlcla 
Further company coverage:  POXEL.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Poxel SA

See all news